Evidence map›Paper›PMID 27616198›Full record

ArticleJournal of virological methods2016

Single-use, electricity-free amplification device for detection of HIV-1.

Kelly A Curtis, Donna L Rudolph, Daphne Morrison, Dylan Guelig, Steven Diesburg, David McAdams, Robert A Burton, Paul LaBarre, Michele Owen

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of virological methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kelly A CurtisLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA. Electronic address: czv2@cdc.gov.
Donna L RudolphLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Daphne MorrisonLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Dylan GueligPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
Steven DiesburgPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
David McAdamsPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
Robert A BurtonPATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
Paul LaBarrePATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
Michele OwenLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA.
Program for Appropriate Technology in Health · USCenters for Disease Control and Prevention · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
CaO-heated DNA amplification obviates electricity requirement at point of careR01EB012641 · NIBIB · PATH · PI BURTON, ROBERT ANDREW · 2011 to 2013
$1.8M
Intramural CDC HHS CC999999NIAID NIH HHS P30 AI027757NIBIB NIH HHS R01 EB012641
6 · The paper itself

Abstract

Early and accurate diagnosis of HIV is key for the reduction of transmission and initiation of patient care. The availability of a rapid nucleic acid test (NAT) for use at the point-of-care (POC) will fill a gap in HIV diagnostics, improving the diagnosis of acute infection and HIV in infants born to infected mothers. In this study, we evaluated the performance of non-instrumented nucleic acid amplification, single-use disposable (NINA-SUD) devices for the detection of HIV-1 in whole blood using reverse-transcription, loop-mediated isothermal amplification (RT-LAMP) with lyophilized reagents. The NINA-SUD heating device harnesses the heat from an exothermic chemical reaction initiated by the addition of saline to magnesium iron powder. Reproducibility was demonstrated between NINA-SUD units and comparable, if not superior, performance for detecting clinical specimens was observed as compared to the thermal cycler. The stability of the lyophilized HIV-1 RT-LAMP reagents was also demonstrated following storage at -20, 4, 25, and 30°C for up to one month. The single-use, disposable NAT minimizes hands-on time and has the potential to facilitate HIV-1 testing in resource-limited settings or at the POC.

Indexed as

Nucleic Acid Amplification TechniquesElectricityHIV-1HIV InfectionsHot TemperatureHumansPoint-of-Care SystemsReproducibility of ResultsRNA, ViralSensitivity and SpecificityRNA, ViralDiagnosisHIV-1Nucleic acid amplificationPoint-of-careRNA

Identifiers

PMID27616198
PMCPMC5056841
OpenAlexW2520530771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.